Ductus venosus pulsatility index as an antenatal screening marker for Down's syndrome: Use with the Combined and Integrated tests

Journal of Medical Screening

Volumn 16, Issue 3, 2009, Pages 112-118

  Borrell, A ^a   Borobio, V ^a   Bestwick, J P ^b   Wald, N J ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; CHORION VILLUS SAMPLING; COMBINED TEST; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DOWN SYNDROME; DUCTUS VENOSUS; DUCTUS VENOSUS PULSATILITY INDEX; FALSE POSITIVE RESULT; FEMALE; FETUS; FETUS DEATH; FIRST TRIMESTER PREGNANCY; HUMAN; INTEGRATED TEST; MAJOR CLINICAL STUDY; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PRENATAL SCREENING; PULSE RATE; SAFETY; SCREENING TEST; SPAIN; ULTRASOUND; URINALYSIS; VEIN BLOOD FLOW;

BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; VENA CAVA, INFERIOR;

EID: 70349956455     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1258/jms.2009.009043     Document Type: Article

References (19)

1. Maiz N, Valencia C, Emmanuel EE, Staboulidou I, Nicolaides KH. Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13 + 6 weeks of gestation. Obstet Gynecol 2008;112:598-605
2. Prefumo F, Sethna F, Sairam S, Bhide A, Thilaganathan B. First-trimester ductus venosus, nasal bones, and Down syndrome in a high-risk population. Obstet Gynecol 2005;105:1348-1354 (Pubitemid 40734268)
3. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75,821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005;25:221-226 (Pubitemid 40432687)
4. Antolín E, Comas C, Torrents M, et al. The role of ductus venosus blood flow assessment in screening for chromosomal abnormalities at 10-16 weeks of gestation. Ultrasound Obstet Gynecol 2001;17:295-300 (Pubitemid 32417442)
5. Borrell A, Martinez JM, Serés A, Borobio V, Cararach V, Fortuny A. Ductus venosus assessment at the time of nuchal translucency measurement in the detection of fetal aneuploidy. Prenat Diagn 2003;11:921-926 (Pubitemid 37463169)
6. Borrell A, Gonce A, Martinez JM, et al. First-trimester screening for Down syndrome with ductus venosus Doppler studies in addition to nuchal translucency and serum markers. Prenat Diagn 2005;25:901-905 (Pubitemid 41494985)
7. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down's syndrome: the results of the serum, urine and ultrasound screening study (SURUSS). J Med Screen 2003;10:56-104 (Pubitemid 36734906)
8. Rubinstein RY, Kroese DP. Simulation and the Monte Carlo Method. 2nd ed. Wiley Series in Probability and Statistics. Hoboken, New Jersey: Wiley, 2008
9. Wald N, Rodeck C, Rudnicka A, Hackshaw A. Nuchal translucency and gestational age. Prenat Diagn 2004;24:150-151
10. Wald NJ, Rodeck C, Hackshaw AK, et al. Correction to the SURUSS report. J Med Screen 2006;13:51-52
11. Morris JK, Wald NJ. Graphical presentation of distributions of risk in screening. J Med Screen 2005;12:155-160
12. Office for National Statistics 1998. Birth Statistics Series FM1 Numbers 25-27. London: HMSO, 1996, 1997, 1998
13. Morris JK, Mutton DE, Alberman E. Revised estimates of the maternal age specific live birth prevalence of Down's syndrome. J Med Screen 2002;9:2-6 (Pubitemid 34327134)
14. Morris JK, Wald NJ, Mutton DE, Alberman E. Comparison of models of maternal age-specific risk for Down syndrome live births. Prenat Diagn 2003;23:252-258 (Pubitemid 36323689)
15. Morris JK, Wald NJ, Watt HC. Fetal loss in Down syndrome pregnancies. Prenat Diagn 1999;19:142-145
16. Gosden C, Tabor A, Leck I, Grant A, Alfirevic Z, Wald N. Amniocentesis and chorionic villus sampling. In: Wald NJ, Leck I, eds. Antenatal and Neonatal Screening. 2nd edn. Oxford: Oxford University Press, 2000:470-516
17. Maiz N, Kagan KO, Milovanovic Z, Celik E, Nicolaides KH. Learning curve for Doppler assessment of ductus venosus flow at 11 + 0 to 13 + 6 weeks' gestation. Ultrasound Obstet Gynecol 2008;31:503-506
18. Braithwaite JM, Kadir RA, Pepera TA, Morris RW, Thompson PJ, Economides DL. Nuchal translucency measurement: training of potential examiners. Ultrasound Obstet Gynecol 1996;8:192-195
19. Matias A, Gomes C, Flack N, Montenegro N, Nicolaides KH. Screening for chromosomal abnormalities at 10-14 weeks: the role of ductus venosus blood flow. Ultrasound Obstet Gynecol 1998;12:380-384 (Pubitemid 29034205)